pioglitazone has been researched along with Urinary Calculi in 4 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Urinary Calculi: Low-density crystals or stones in any part of the URINARY TRACT. Their chemical compositions often include CALCIUM OXALATE, magnesium ammonium phosphate (struvite), CYSTINE, or URIC ACID.
Excerpt | Relevance | Reference |
---|---|---|
" Ten-week-old male OLETF and LETO rats were divided into three groups of nine each and treated with vehicle or oral administration of 3 or 10 mg/kg/day pioglitazone, an agent that improves insulin resistance." | 3.76 | Insulin resistance increases the risk of urinary stone formation in a rat model of metabolic syndrome. ( Fujii, R; Hara, I; Iba, A; Inagaki, T; Kohjimoto, Y; Kuramoto, T; Matsumura, N; Mori, T; Nanpo, Y; Nishizawa, S; Shintani, Y, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Assimos, DG | 2 |
Suzuki, S | 1 |
Arnold, LL | 1 |
Pennington, KL | 1 |
Kakiuchi-Kiyota, S | 1 |
Wei, M | 1 |
Wanibuchi, H | 1 |
Cohen, SM | 1 |
Iba, A | 1 |
Kohjimoto, Y | 1 |
Mori, T | 1 |
Kuramoto, T | 1 |
Nishizawa, S | 1 |
Fujii, R | 1 |
Nanpo, Y | 1 |
Matsumura, N | 1 |
Shintani, Y | 1 |
Inagaki, T | 1 |
Hara, I | 1 |
4 other studies available for pioglitazone and Urinary Calculi
Article | Year |
---|---|
Re: Increased Production and Reduced Urinary Buffering of Acid in Uric Acid Stone Formers is Ameliorated by Pioglitazone.
Topics: Humans; Kidney Calculi; Pioglitazone; Uric Acid; Urinary Calculi | 2019 |
Re: Increased Production and Reduced Urinary Buffering of Acid in Uric Acid Stone Formers is Ameliorated by Pioglitazone.
Topics: Humans; Kidney Calculi; Pioglitazone; Uric Acid; Urinary Calculi | 2019 |
Effects of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on the urine and urothelium of the rat.
Topics: Animals; Body Weight; Gene Expression; Hypoglycemic Agents; Male; Organ Size; Pioglitazone; PPAR gam | 2010 |
Insulin resistance increases the risk of urinary stone formation in a rat model of metabolic syndrome.
Topics: Animals; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin Resistance; Male; Metabolic Syndrom | 2010 |